Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Advanced Composites
LeftNav
Aerospace
LeftNav
Amorphous Metal Structures
LeftNav
Analysis and Simulation
LeftNav
Asbestos and Substitutes
LeftNav
Associations, Research Organisations and Universities
LeftNav
Automation Equipment
LeftNav
Automotive
LeftNav
Biomaterials
LeftNav
Building Materials
LeftNav
Bulk Handling and Storage
LeftNav
CFCs and Substitutes
LeftNav
Company
LeftNav
Components
LeftNav
Consultancy
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
 
News

A new weapon to disable bacteria discovered

Max Planck Society : 02 May, 2002  (New Product)
The mechanism with which blood cells use an enzyme, called elastase, to neutralize the bacterial defenses that cause disease, was discovered by researchers Arturo Zychlinsky at the Max Planck Institute for Infection Biology in Berlin and Yvette Weinrauch at New York University School of Medicine.
White blood cells imprison bacteria in tightly fitting compartments or vacuoles. Within these vacuoles, the cells release noxious substances that kill the bacteria. This is why most of the time our bodies can take care of small wounds or mild infections. Sometimes, however, we get infected with bacteria equipped with highly evolved defenses that target white blood cells, the very cells that are supposed to defend us. A case in point is dysentery, a serious, bloody form of diarrhea. It is caused by bacteria called Shigella. This is a devastating disease that claims millions of lives every year, especially among children in the developing world.

Shigella uses disease-causing (virulent) proteins to attack human cells. Shigella uses these virulent proteins to invade any cell in the body and then to escape from the cellular prison, the vacuole. Weinrauch and Zychlinsky recognized a contradiction: if Shigella escapes the vacuolar prison, the infection should always be lethal. Yet, most people recover after suffering an acute infection.

Weinrauch and Zychlinsky reasoned that the answer could be found in a specialized white blood cell, the neutrophil. Neutrophils were prime suspects for two reasons. Firstly, they are very abundant in the response to Shigella infections, and secondly, they are equipped with defense mechanisms that kill bacteria when confined to a vacuolar prison. In collaboration with Jerry Weiss, now at Iowa University, the investigators found that surprisingly, neutrophils, unlike any other type of cells, can enclose Shigella within the vacuoles.

Investigations into the reason why Shigella is enclosed within neutrophil vacuoles led Weinrauch and Zychlinsky to discover how the neutrophil can neutralize not only Shigella but also other disease causing bacteria. Neutrophils produce an enzyme, elastase, which can destroy Shigella's escape proteins with amazing efficiency before they can leave the vacuole. In this manner neutrophils retain the Shigella long enough to mobilize other defenses that can destroy the bacteria. Indeed, neutrophils with inactivated elastase cannot contain Shigella in a vacuole, and the bacteria remains virulent, as shown in collaboration with Steve Shapiro of Harvard Medical School. Interestingly, elastase destroys virulent proteins not only in Shigella, but also in Salmonella, the cause of typhoid fever and in Yersinia, the cause of Bubonic plague.

Many questions remain regarding the timely delivery of elastase and how it can recognize virulent proteins within bacteria. This new insight, however, may allow the development of a new generation of antibiotics that would rely on neutralizing the virulent proteins of disease-causing bacteria rather than indiscriminately killing microbes.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 NewMaterials.com
Netgains Logo